Vanderbilt Integrated Community TMS for Opioid Recovery (VICTORY): Study protocol for a randomized, controlled trial of non-invasive brain stimulation to reduce craving in people with opioid use disorder
Open Access
- 10 September 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357402
Abstract
Background: Individuals receiving buprenorphine treatment for opioid use disorder (OUD) remain at high risk for treatment discontinuation and return to opioid use. Transcranial magnetic stimulation (TMS) has shown efficacy in reducing craving and substance use in other substance use disorders, but its application in OUD remains limited and the neural mechanism underlying its therapeutic effects is poorly understood. Determining the feasibility and generalizability of TMS in patients receiving buprenorphine – the most commonly prescribed medication for OUD – is therefore critical. This protocol aims to address these issues in a clinical trial of weekly TMS sessions for OUD. Methods: We will enroll up to 120 individuals with OUD taking buprenorphine in a randomized, single-blind, sham-controlled trial of left dorsolateral prefrontal cortex (DLPFC)-targeted intermittent theta burst stimulation (iTBS). Participants will receive active or sham iTBS weekly (2 sessions of 1800 pulses each applied once per week x 8 weeks, 16 sessions total) with pre- and post-iTBS assessments (10, 12, 20 weeks) of craving, opioid use, and treatment retention. A subset of individuals will undergo optional pre- and post-iTBS neuroimaging. The study will be conducted at an academic medical center and a private outpatient TMS clinic. Aims: Our primary aim is to determine whether 16 sessions of active iTBS applied to the left DLPFC results in reduced craving and opioid use, and higher treatment retention, relative to sham. In a secondary aim, we will also examine whether iTBS-related changes in craving are associated with changes in functional connectivity between the left DLPFC and both the dorsal striatum and anterior cingulate cortex. Discussion: By evaluating the feasibility and efficacy of a weekly TMS protocol that aligns with routine care and focuses on patients maintained on buprenorphine, this study addresses key limitations of prior TMS research in OUD. Furthermore, the inclusion of neuroimaging will help characterize the neural mechanisms underlying TMS-related changes in craving. Trial registration: This clinical trial is registered at ClinicalTrials.Gov; ID NCT07457489 ; date of registration: 03/02/2026.Keywords
Funding Information
- Tennessee Opioid Abatement Council
- National Institute on Drug Abuse (K23DA059690)
This publication has 60 references indexed in Scilit:
- Association of Drug Cues and Craving With Drug Use and RelapseJAMA Psychiatry, 2022
- Insights into the Neurobiology of Craving in Opioid Use DisorderCurrent Anesthesiology Reports, 2020
- Time to Reconsider the Role of Craving in Opioid Use DisorderJAMA Psychiatry, 2019
- Buprenorphine Treatment for Opioid Use Disorder: An OverviewCNS Drugs, 2019
- Prevention and Treatment of Opioid Misuse and AddictionJAMA Psychiatry, 2019
- The left dorsolateral prefrontal cortex and caudate pathway: New evidence for cue-induced craving of smokersHuman Brain Mapping, 2017
- Impaired Functional Connectivity Within and Between Frontostriatal Circuits and Its Association With Compulsive Drug Use and Trait Impulsivity in Cocaine AddictionJAMA Psychiatry, 2015
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid DependenceArchives of General Psychiatry, 2011
- Multiple imputation by chained equations: what is it and how does it work?International Journal of Methods in Psychiatric Research, 2011
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010